UNSPSC 51412703: Naftidrofuryl hydrogen oxalate

This classification denotes a vasodilating agent and serotonin antagonist with the molecular formula C24H33NO3.C2H2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5ADB8D9388, chemically known as 2-furanpropionic acid, tetrahydro-.alpha.-(1-naphthylmethyl)-, 2-(diethylamino)ethyl esteroxalate (1:1) but more generally known as nafronyl oxalate, which bears US NIH Compound Identifier 4417. European Medicines Agency schedules Nafronyl oxalate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20719.

Most nations, for tariff and trade purposes, schedule naftidrofuryl hydrogen oxalate under HS 29321900. SMILES: CCN(CC)CCOC(=O)C(CC1CCCC2C1CCCC2)CC3CCCO3.C(=O)(C(=O)O)O.

UNSPSC 51412703 Naftidrofuryl hydrogen oxalate is a Commodity code covering advanced life support and emergency pharmaceutical medications used by fire, rescue, and emergency medical services in state and local jurisdictions. State and local governments procure specific Emergency Medical Service (EMS) injectable medications under this code—particularly vasodilators, vasoconstrictors, and cardiac agents used in pre-hospital critical care. The City of Tampa Fire Rescue's April 2026 bid for Advanced Life Support Medications exemplifies the scope: sealed bids were solicited for four medication line items (Labetalol, Epinephrine, Adenosine, and Diltiazem) with firm pricing including shipping, material warranties, and expiration-date management. Issuing bodies are typically municipal fire and rescue departments operating under city purchasing offices, sometimes coordinated at the county level. Procurement is predominantly through formal IFB (Invitation for Bid) processes with sealed-bid submission, short response windows, and award to the lowest responsive, responsible bidder.

The most recent posted opportunity shows activity in Florida, specifically Hillsborough County through the City of Tampa's Purchasing Department. Tampa Fire Rescue's 26P00188 bid, posted April 24, 2026, with a due date of April 8, 2026, carried an estimated contract value of $40,000 and included a Small Local Business Enterprise (SLBE) sheltered market designation with a 5 percent bid discount (not to exceed $10,000) for qualified firms. The contract term ran one year from award with two additional one-year renewal options plus unilateral City extension rights for up to three 30-day periods. Vendors were required to supply medications with minimum nine-month shelf life, deliver within ten calendar days of order, maintain a one-year warranty, and arrange replacement of expired stock. All proposers had to submit OSHA-compliant Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation per Section 508 standards.